Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - FREE CASH FLOW
Free Cash Flow EBS - Emergent BioSolutions Inc.
-258 M
LAST VALUE
-91.93%
2 YEAR CAGR
-53.46%
5 YEAR CAGR
-19.00%
10 YEAR CAGR